Rotate your device

Please rotate your device to landscape mode
for the best experience.

Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Myject S 360mg Tablet DR

Prescription Icon
Prescription Required

Marketer

Septalyst Lifesciences Pvt.Ltd.

Salt Composition

Mycophenolate sodium (360mg)

Overview Myject S 360mg Tablet DR

Immunosuppressant Myject S 360mg DR tablets help prevent organ rejection post-transplant. Used in conjunction with other medications, it reduces the body's immune response to the new organ (kidney, heart, liver, etc.). Dosage is transplant-specific; adhere strictly to your physician's prescription. This medication can be taken with or without food, swallowed whole – never crushed, chewed, broken, or opened. Consistent use is crucial; discontinuation increases rejection risk. Treatment duration is determined by your doctor. Common side effects include gastrointestinal upset (nausea, vomiting, diarrhea, abdominal pain), headache, hypertension, and altered white blood cell counts. Immunosuppression elevates infection susceptibility and cancer risk. A comprehensive list of potential side effects, some serious and requiring immediate medical attention, is available from your doctor. Myject S 360mg DR is contraindicated during pregnancy, breastfeeding, or pregnancy planning due to the risk of birth defects and miscarriage. Consult your physician before use if you have infections, unusual bleeding or bruising, a history of digestive issues, or are taking other medications, as interactions are possible. Regular blood tests will monitor blood cell counts. Report any unexplained bruising/bleeding, sore throat, mouth sores, or fever to your doctor promptly.

Uses of Myject S 360mg Tablet DR

Preventing organ transplant rejection

Major Benefits of Myject S 360mg Tablet DR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Myject S 360mg Delayed-Release Tablet can be administered with or without food, although consistent timing is recommended.

Common Side effects of Myject S 360mg Tablet DR:

  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal pain
  • Headache
  • High blood pressure
  • Decreased white blood cell count (neutrophils)
  • Bacterial infection
  • Fungal infection
  • Pneumonia
  • Increased uric acid level in blood
  • Electrolyte imbalance
  • Anxiety
  • Breathlessness
  • Increased creatinine level in blood
  • Anemia (low number of red blood cells)
  • Acne
  • Muscle pain

How to use Myject S 360mg Tablet DR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Myject S 360mg Delayed-Release Tablets can be consumed with or without food, though consistent timing is recommended.

How Myject S 360mg Tablet DR works:

Myject S 360mg Extended-Release Tablets function as an immunosuppressant, mitigating the body's immune response and thus hindering rejection of transplanted organs.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse interactions between Myject S 360mg Tablet DR and alcohol consumption.

PregnancyPregnancyCONSULT YOUR DOCTOR

Employing Myject S 360mg Tablet DR during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. Nevertheless, in exceptionally rare, life-threatening circumstances, a physician might deem its use justifiable if the potential advantages outweigh the inherent dangers. Physician consultation is essential.

Breast feedingBreast feedingUNSAFE

The drug Myject S 360mg Tablet DR is contraindicated during lactation due to potential infant toxicity.

DrivingDrivingSAFE

Driving ability is typically unaffected by Myject S 360mg Delayed-Release Tablets.

KidneyKidneyCAUTION

Patients with severe renal impairment should exercise caution when using Myject S 360mg Tablet DR. Dosage modification of Myject S 360mg Tablet DR may be necessary. Physician consultation is advised.

LiverLiverSAFE IF PRESCRIBED

The use of Myject S 360mg Tablet DR in patients with liver impairment appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.

What if you forget to take Myject S 360mg Tablet DR :

Should you forget a Myject S 360mg Tablet DR dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Myject S 360mg Tablet DR

LabelValue
Chemical Type Phthalide-based compound
Developing Habits No.
Treatment Category Cancer Therapeutics
Behavior Class Purine analog immunosuppressants
Myject S 360mg Tablet DR
949